You are probably right, but the ongoing problem is money.
Possible money sources have apparently decided that funding anatabine is too risky. That is hard to understand as anatabine seems to be a safe and effective anti-inflammatory!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.